American Bio Medica Corporation (ABMC) Company Profile

American Bio Medica Corporation Company Snapshot

American Bio Medica Corporation operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares American Bio Medica with three other companies in this sector in UNITED STATES : Cue Biopharma Inc (2019 sales of $3.46 million ), CTI BioPharma Corp ($3.35 million of which 100% was License & Contract Revenues), and Zogenix Incorporation ($3.65 million of which 100% was Pharmaceutical produc).

Sales Analysis. During the year ended December of 2019, sales at American Bio Medica were $3.66 million. This is a decrease of 5.6% versus 2018, when the company's sales were $3.87 million.

American Bio Medica Corporation

Stock Data:

Recent Stock Performance:

Current Price (7/31/2020): .73
(Figures in U.S. Dollars)

1 Week	2.8%	13 Weeks	-28.4%

4 Weeks	386.7%	52 Weeks	857.4%

American Bio Medica Corporation Key Data:

Ticker:	ABMC	Country:	United States

Exchanges:	OTC	Major Industry:	Pharmaceuticals & Biotechnology

		Sub Industry:	Pharmaceutical Preparations

2019 Sales	3,655,000 (Year Ending Jan 2020).	Employees:	80

Currency:	U.S. Dollars	Market Cap:	23,857,118

Fiscal Yr Ends:	December	Shares Outstanding:	32,680,984

Share Type:	Common	Closely Held Shares:	15,603,384

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.